{
    "Humans": 0.2224293621,
    "Female": 0.1607049228,
    "Breast Neoplasms": 0.1107660938,
    "Middle Aged": 0.0954908244,
    "Aged": 0.0791203029,
    "Adult": 0.0760209729,
    "Male": 0.0529158171,
    "breast cancer": 0.0409204777,
    "Prognosis": 0.0318263909,
    "Aged, 80 and over": 0.0314477134,
    "Risk Factors": 0.0286454996,
    "Neoplasms": 0.0265307311,
    "United States": 0.0223652782,
    "Retrospective Studies": 0.0216894844,
    "Neoplasm Staging": 0.0195339353,
    "Animals": 0.0191436062,
    "Registries": 0.0181939994,
    "Mammography": 0.0171570055,
    "Incidence": 0.0170463152,
    "Biomarkers, Tumor": 0.0165802505,
    "Young Adult": 0.0162889601,
    "patients": 0.0149373726,
    "Breast cancer": 0.0146868628,
    "Cohort Studies": 0.0146227789,
    "Gene Expression Regulation, Neoplastic": 0.0146053015,
    "Treatment Outcome": 0.014529566,
    "Adolescent": 0.0139644626,
    "Follow-Up Studies": 0.0138654238,
    "Age Factors": 0.0132071075,
    "Cell Line, Tumor": 0.0128226041,
    "Survival Rate": 0.012612875,
    "Gene Expression Profiling": 0.0118729974,
    "Receptors, Estrogen": 0.0118613458,
    "Algorithms": 0.0117914361,
    "Survival Analysis": 0.0117797844,
    "Time Factors": 0.0112612875,
    "Receptor, ErbB-2": 0.0107369648,
    "Mass Screening": 0.0105913195,
    "Genetic Predisposition to Disease": 0.0105854937,
    "Case-Control Studies": 0.0105563647,
    "Early Detection of Cancer": 0.0104223711,
    "Neoplasm Recurrence, Local": 0.0103757646,
    "Prospective Studies": 0.0103699388,
    "Antineoplastic Agents": 0.0100786484,
    "Risk Assessment": 0.0098922225,
    "Mice": 0.0098863967,
    "Proportional Hazards Models": 0.0096475386,
    "cancer": 0.0094611127,
    "Mutation": 0.0092164288,
    "Reproducibility of Results": 0.0091639965
}